{
    "2018-01-05": [
        [
            {
                "time": "2017-10-25",
                "original_text": "How Novo Nordisk’s Biopharmaceuticals Segment Performed in 3Q17",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Biopharmaceuticals",
                        "3Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2017-10-25",
                "original_text": "How Did Novo Nordisk’s Victoza and Saxendra Perform in 3Q17?",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Victoza",
                        "Saxendra",
                        "3Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2017-10-25",
                "original_text": "How Did Novo Nordisk’s Modern Insulin Segment Perform in 3Q17?",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Modern Insulin",
                        "3Q17"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "3 Large-Cap Pharma Stocks to Watch Out for This New Year",
                "features": {
                    "keywords": [
                        "Large-Cap",
                        "Pharma",
                        "Stocks",
                        "New Year"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2017-10-25",
                "original_text": "Orexigen Struggles as Contrave Commercialization Costs Rise",
                "features": {
                    "keywords": [
                        "Orexigen",
                        "Contrave",
                        "Commercialization Costs"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}